Abstract: A nucleotide probe complex which enhances the ability to discriminate low level samples in electrochemiluminescent assays. The complex is composed of a platform molecule to which multiple copies of an organometallic electrochemiluminescent label and an oligonucleotide probe are separately attached. Preferably the complex is capped with streptavidin. Use of the complex permits detection of 1000 copies of analyte per sample in less than one hour.
Abstract: Catalytic antibody components, methods for producing catalytic antibody components, methods for using catalytic antibody components, in particular, single chain and smaller components are disclosed. Catalytic antibody components able to promote the cleavage or formation of an amide, peptide, ester or glycosidic bond, and which are prepared from monoclonal catalytic antibodies, catalytic autoantibodies or by site-directed mutagenesis are disclosed. Methods of using catalytic antibody components alone or in combination with other antibody components or other biological moieties are disclosed.
Type:
Grant
Filed:
March 9, 1995
Date of Patent:
August 19, 1997
Inventors:
Sudhir Paul, Michael J. Powell, Richard J. Massey, John H. Kenten
Abstract: Detectable compounds comprising a chemically-transformable first compound covalently linked to an electrochemiluminescent compound are provided. Such compounds are useful in processes and kits that monitor the status of the first compound and derive information from such monitoring.
Abstract: A rapid single step assay suitable for the detection or quantification of .beta.-lactam antibiotics and .beta.-lactamases. The assay can be performed directly on samples of food, such as milk and meat, blood or serum and is useful in determining the suitability of a particular antibiotic in treating a particular bacterial infection and in diagnosis of a bacterial infection. The assay is also useful in determining and quantifying .beta.-lactam antibiotic resistance. The assay can be performed on an IGEN Origen.sup.R Analyzer.
Abstract: This invention is directed to a process for performing a competitive, electrochemiluminescence assay for endotoxins. In particular, the invention involves the use of ruthenium (II)tris-bipyridine NHS ester label to detect the labeled endotoxins.
Abstract: Images comprised of silver such as X-rays and electrophoresis gel bands, wherein the size and darkness of the image provides useful information, are quantitated utilizing a spectrophotometer to quantify the silver which comprises the image. An image is isolated from X-ray film or an electrophoresis gel followed by removal therefrom of any silver which is present. The removed silver is complexed to cause an optical change. A spectrophotomer is then used to measure the absorbance and the absorbance measurement is compared with a calibrated reference standard.
Abstract: The present invention provides a composition of matter useful for enhancing the viability of hybridomas in culture which comprises a partially purified, cell-free extract derived from a medium conditioned by mitogen-stimulated macrophages, the extract being substantially free of the macrophage stimulating mitogen which had been added to the medium, and having within it a component characterized by the ability to enhance the viability of hybridomas in culture, and by an apparent molecular weight in the range from about 35,000 to about 45,000. Also provided are methods of preparing the composition of matter, and methods for enhancing the viability of hybridomas in culture.